Search

everythinglearnresearchcommunity

for

Search:↓

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Both mouse and rat models are effective for testing alopecia areata treatments.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Genetically modified plants could be an important source of omega-3 fats to meet global needs.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

The document suggests a possible link between Crohn's disease and Johne's disease and calls for more research.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Ketoconazole cured about 70% of cutaneous leishmaniasis cases caused by Leishmania major.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.